Immunoactivating Peptide P4 Augments Alveolar Macrophage Phagocytosis in Two Diverse Human Populations

New treatment strategies are urgently needed to overcome early mortality in acute bacterial infections. Previous studies have shown that administration of a novel immunoactivating peptide (P4) alongside passive immunotherapy prevents the onset of septicemia and rescues mice from lethal invasive dise...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bangert, Mathieu, Wright, Adam K., Rylance, Jamie, Kelly, Matthew J., Wright, Angela D., Carlone, George M., Sampson, Jacquelyn S., Rajam, Gowrisankar, Ades, Edwin W., Kadioglu, Aras, Gordon, Stephen B.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2013
Assuntos:
Experimental Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3754341/
https://ncbi.nlm.nih.gov/pubmed/23817378
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00742-13
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados